HCA vs. GILD, BMY, ZTS, GSK, MCK, CI, BDX, BSX, REGN, and VRTX
Should you be buying HCA Healthcare stock or one of its competitors? The main competitors of HCA Healthcare include Gilead Sciences (GILD), Bristol-Myers Squibb (BMY), Zoetis (ZTS), GSK (GSK), McKesson (MCK), The Cigna Group (CI), Becton, Dickinson and Company (BDX), Boston Scientific (BSX), Regeneron Pharmaceuticals (REGN), and Vertex Pharmaceuticals (VRTX). These companies are all part of the "medical" sector.
Gilead Sciences (NASDAQ:GILD) and HCA Healthcare (NYSE:HCA) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.
HCA Healthcare has a net margin of 8.20% compared to HCA Healthcare's net margin of 1.76%. Gilead Sciences' return on equity of 674.49% beat HCA Healthcare's return on equity.
Gilead Sciences has a beta of 0.22, suggesting that its share price is 78% less volatile than the S&P 500. Comparatively, HCA Healthcare has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500.
Gilead Sciences has higher earnings, but lower revenue than HCA Healthcare. HCA Healthcare is trading at a lower price-to-earnings ratio than Gilead Sciences, indicating that it is currently the more affordable of the two stocks.
Gilead Sciences currently has a consensus target price of $83.69, indicating a potential upside of 23.58%. HCA Healthcare has a consensus target price of $317.00, indicating a potential downside of 1.82%. Given HCA Healthcare's higher possible upside, equities analysts plainly believe Gilead Sciences is more favorable than HCA Healthcare.
83.7% of Gilead Sciences shares are held by institutional investors. Comparatively, 62.7% of HCA Healthcare shares are held by institutional investors. 0.2% of Gilead Sciences shares are held by insiders. Comparatively, 1.6% of HCA Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Gilead Sciences received 1251 more outperform votes than HCA Healthcare when rated by MarketBeat users. Likewise, 77.37% of users gave Gilead Sciences an outperform vote while only 77.33% of users gave HCA Healthcare an outperform vote.
In the previous week, HCA Healthcare had 8 more articles in the media than Gilead Sciences. MarketBeat recorded 23 mentions for HCA Healthcare and 15 mentions for Gilead Sciences. HCA Healthcare's average media sentiment score of 0.55 beat Gilead Sciences' score of 0.27 indicating that Gilead Sciences is being referred to more favorably in the media.
Gilead Sciences pays an annual dividend of $3.08 per share and has a dividend yield of 4.5%. HCA Healthcare pays an annual dividend of $2.64 per share and has a dividend yield of 0.8%. Gilead Sciences pays out 855.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. HCA Healthcare pays out 13.2% of its earnings in the form of a dividend. Gilead Sciences has raised its dividend for 9 consecutive years and HCA Healthcare has raised its dividend for 5 consecutive years. Gilead Sciences is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Summary
HCA Healthcare beats Gilead Sciences on 11 of the 21 factors compared between the two stocks.
Get HCA Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HCA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
HCA Healthcare Competitors List
Related Companies and Tools